201 related articles for article (PubMed ID: 20930860)
1. Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.
Longo SL; Griffith C; Glass A; Shillitoe EJ; Post DE
Cancer Gene Ther; 2011 Feb; 18(2):123-34. PubMed ID: 20930860
[TBL] [Abstract][Full Text] [Related]
2. An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.
Griffith C; Noonan S; Lou E; Shillitoe EJ
Cancer Gene Ther; 2007 Dec; 14(12):985-93. PubMed ID: 17853922
[TBL] [Abstract][Full Text] [Related]
3. Tumour-specific triple-regulated oncolytic herpes virus to target glioma.
Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW
Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093
[TBL] [Abstract][Full Text] [Related]
4. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.
Xiao W; Pizer LI; Wilcox KW
J Virol; 1997 Mar; 71(3):1757-65. PubMed ID: 9032304
[TBL] [Abstract][Full Text] [Related]
5. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
6. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
Lee LY; Schaffer PA
J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the immediate-early gene product ICP4 is necessary for the genome of the herpes simplex virus type 1 ICP4 deletion mutant strain d120 to circularize in infected cells.
Su YH; Zhang X; Wang X; Fraser NW; Block TM
J Virol; 2006 Dec; 80(23):11589-97. PubMed ID: 16987974
[TBL] [Abstract][Full Text] [Related]
8. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27.
Zhu Z; Schaffer PA
J Virol; 1995 Jan; 69(1):49-59. PubMed ID: 7983745
[TBL] [Abstract][Full Text] [Related]
9. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.
Wu N; Watkins SC; Schaffer PA; DeLuca NA
J Virol; 1996 Sep; 70(9):6358-69. PubMed ID: 8709264
[TBL] [Abstract][Full Text] [Related]
10. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
Lee CY; Bu LX; Rennie PS; Jia WW
Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4.
Samaniego LA; Webb AL; DeLuca NA
J Virol; 1995 Sep; 69(9):5705-15. PubMed ID: 7637016
[TBL] [Abstract][Full Text] [Related]
12. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
[TBL] [Abstract][Full Text] [Related]
13. Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Krüppel-Like Transcription Factor 4/Sp1 Binding Sites.
Ostler JB; Thunuguntla P; Hendrickson BY; Jones C
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208447
[TBL] [Abstract][Full Text] [Related]
14. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
15. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
[TBL] [Abstract][Full Text] [Related]
16. The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.
Wagner LM; Lester JT; Sivrich FL; DeLuca NA
J Virol; 2012 Jun; 86(12):6862-74. PubMed ID: 22496239
[TBL] [Abstract][Full Text] [Related]
17. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.
Yao F; Schaffer PA
J Virol; 1995 Oct; 69(10):6249-58. PubMed ID: 7666525
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.
Peri P; Mattila RK; Kantola H; Broberg E; Karttunen HS; Waris M; Vuorinen T; Hukkanen V
Virol J; 2008 Nov; 5():140. PubMed ID: 19025601
[TBL] [Abstract][Full Text] [Related]
19. Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
Peters C; Paget M; Tshilenge KT; Saha D; Antoszczyk S; Baars A; Frost T; Martuza RL; Wakimoto H; Rabkin SD
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793956
[TBL] [Abstract][Full Text] [Related]
20. Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
Kuroda T; Martuza RL; Todo T; Rabkin SD
BMC Biotechnol; 2006 Sep; 6():40. PubMed ID: 16995942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
